Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy

Journal of Clinical Investigation

Volumn 124, Issue 5, 2014, Pages 1896-1898

  Indolfi, Ciro ^a,b   Curcio, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21; MYOSIN HEAVY CHAIN ALPHA;

BASE PAIRING; BLOOD VESSEL INJURY; CAUSE OF DEATH; CELL COMMUNICATION; CONGESTIVE CARDIOMYOPATHY; ENDOTHELIUM CELL; EXOSOME; FIBROBLAST; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE MAPPING; GROWTH REGULATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; HUMAN; ISCHEMIC CARDIOMYOPATHY; MULTIVESICULAR BODY; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUDDEN CARDIAC DEATH; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARDIOMEGALY; EXOSOMES; FIBROBLASTS; MICRORNAS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION;

EID: 84899769353     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75801     Document Type: Review

References (26)

1. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med. 1970;72(6):813-822.
2. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32(5):1454-1459.
3. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane- spanning receptors and heart function. Nature. 2002;415(6868):206-212.
4. Maillet M, van Berlo JH, Molkentin JD. Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol. 2013; 14(1):38-48.
5. Indolfi C, et al. Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation. 2002; 106(16):2118-2124.
6. De Rosa S, Curcio A, Indolfi C. Emerging role of microRNAs in cardiovascular diseases. Circ J. 2014; 78(3):567-575.
7. Torella D, et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res. 2011; 109(8):880-893.
8. Iaconetti C, et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res Cardiol. 2012; 107(5):296.
9. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011;124(18):1936-1944.
10. Carè A, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13(5):613-618.
11. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress dependent cardiac growth and gene expression by a microRNA. Science. 2007;316(5824):575-579.
12. Ucar A, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun. 2012;3:1078.
13. Curcio A, et al. MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS One. 2013;8(7):e70158.
14. Elia L, et al. Reciprocal regulation of microRNA- 1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009;120(23):2377-2385.
15. da Costa Martins PA, et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation. 2008; 118(15):1567-1576.
16. Pan W, et al. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS One. 2013;8(1):e53950.
17. Abonnenc M, et al. Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res. 2013;113(10):1138-1147.
18. Huan J, et al. RNA trafficking by acute myelogenous leukemia exosomes. Cancer Res. 2013; 73(2):918-929.
19. Hergenreider E, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012; 14(3):249-256.
20. Laffont B, et al. Activated platelets can deliver mRNA regulatory Ago2 microRNA complexes to endothelial cells via microparticles. Blood. 2013; 122(2):253-261.
21. Bang C, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014; 124(5):2136-2146.
22. Wang B, Golemis EA, Kruh GD. ArgBP2, a multiple Src homology 3 domain-containing, Arg/ Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks. J Biol Chem. 1997; 272(28):17542-17550.
23. Kakimoto Y, et al. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients. J Am Heart Assoc. 2013; 2(6):e000565.
24. Cheng H, et al. Loss of enigma homolog protein results in dilated cardiomyopathy. Circ Res. 2010; 107(3):348-356.
25. Osio A, et al. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res. 2007; 100(6):766-768.
26. Lanford RE, et al. Therapeutic silencing of microRNA- 122 in primates with chronic hepatitis C virus infection. Science. 327(5962):198-201.